<DOC>
	<DOCNO>NCT01934101</DOCNO>
	<brief_summary>Primary Objective : • To determine safety tolerability single multiple ascend oral dos CHR-5154 healthy volunteer . Secondary Objectives : - To determine pharmacokinetic profile CHR-5154 metabolite CHR-5426 . - To compare pharmacokinetic profile CHR-5154 CHR-5426 single dose CHR-5154 fed fast state .</brief_summary>
	<brief_title>Phase 1 Dose Escalating Study Assess Safety , Tolerability , Food Effect PK CHR-5154 Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>1 . Healthy male volunteer age 1845 . 2 . Nonsmokers least three month receive first dose study drug duration study . 3 . Body mass index ( BMI ) ≥ 18 ≤ 32 kg/m2 . 4 . Body weight ≥ 50 kg ≤ 120 kg screening . 5 . Able voluntarily provide write informed consent participate study . 6 . Must understand purpose risk study agree follow restriction schedule procedure define protocol , confirm informed consent process . 7 . Sexually active male volunteer must use two highly effective method contraception partner throughout study 90 day completion study . 8 . Male volunteer must donate sperm study 90 day completion study . 9 . Must willing consent data enter The Over Volunteering Prevention System ( TOPS ) . 10 . The volunteer 's primary care physician must confirm nothing medical history would preclude enrolment clinical study 1 . Volunteers history presence significant cardiovascular disease , pulmonary , hepatic , gallbladder biliary tract , renal , haematologic , gastrointestinal , endocrine , immunologic , dermatologic , neurologic , psychiatric disease current infection . 2 . Laboratory value screen baseline deem clinically significant . 3 . QTcF great 450 msec screening . 4 . Positive human immunodeficiency virus ( HIV ) , hepatitis B hepatitis C. 5 . Current history drug alcohol abuse positive drug abuse alcohol test screening checkin . 6 . Participation clinical drug study 90 day precede initial dose study . 7 . Any clinically significant illness within 30 day prior study drug administration . 8 . Donation blood blood product within 90 day prior study drug administration , time study , except require protocol . 9 . Volunteers history presence significant drug allergy . 10 . Use prescription overthecounter medication ( include vitamin , herbal mineral supplement ) within 30 day prior study drug administration end study , exception occasional paracetamol approve Investigator . 11 . Strenuous exercise , judge Investigator , within 72 hour prior screen , within 72 hour prior study drug administration duration study poststudy medical . 12 . Weekly alcohol intake exceed equivalent 21 unit per week . 13 . Consumption alcoholic beverage within 24 hour prior study drug administration study confinement . 14 . Consumption caffeine xanthinecontaining product within 24 hour prior confinement study confinement . 15 . Consumption grapefruit , grapefruit juice , Seville oranges , Seville orange marmalade product contain grapefruit Seville oranges within 7 day prior confinement study confinement . 16 . Volunteers , opinion Investigator , unsuitable participation study .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>